1
Eslicarbazepine Acetate Monotherapy Long Term Study
Condition(s):EpilepsyLast Updated:July 17, 2018Completed
Eslicarbazepine Acetate as an Intervention: 69 Clinical Trials, Page 1 of 7
Hide Studies Not Open or Pending
2
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
Condition(s):Partial EpilepsyLast Updated:October 24, 2014Completed
3
Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites
Condition(s):EpilepsyLast Updated:May 19, 2017Completed
4
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
Condition(s):EpilepsyLast Updated:August 7, 2017Completed
5
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
Condition(s):Epilepsy With Partial On-set SeizuresLast Updated:June 16, 2020Completed
6
Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
Condition(s):EpilepsyLast Updated:December 10, 2014Completed
7
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Condition(s):EpilepsyLast Updated:January 16, 2018Withdrawn
8
The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093
Condition(s):EpilepsyLast Updated:May 8, 2017Completed
9
Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
Condition(s):EpilepsyLast Updated:June 4, 2019Completed
10
Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate
Condition(s):EpilepsyLast Updated:January 12, 2015Completed